Table 2. Multivariable Models for Overall Survival and Progression-Free Survival of BRCA wild type OvCa patients with different BRCAness status.

	Overall Survival				Progression-Free Survival
	3-Year Rate, % (95% CI)	5-Year Rate, % (95% CI)	HR (95% CI)	P Value	3-Year Rate, % (95% CI)	5-Year Rate, % (95% CI)	HR (95% CI)	P Value
BRCAness
Hypomutation	40(26-60)	15 (7-36)	1 [Reference]		8(2-27)	0*	1 [Reference]
Intermediate	61(53-71)	34(16-35)	0.60(0.39-0.91)	0.016	16(10-26)	12(6-21)	0.80(0.53-1.21)	0.29
BRCAness	75(56-100)	55(32-93)	0.33(0.15-0.69)	0.004	31(13-75)	21(6-68)	0.51(0.24-1.08)	0.077
Tumor Stage
II	89(71-100)	67(36-100)	1 [Reference]		75(50-100)	37(9-100)	1 [Reference]
III	59(51-68)	21(14-31)	2.34(0.73-7.43)	0.15	13(8-21)	8(4-16)	4.06(1.27-12.92)	0.018
IV	48(33-70)	34(20-58)	2.40(0.71-8.08)	0.16	14(5-39)	14 (5-39)	4.22(1.25-14.22)	0.020
Age increase of 1.0 ye			1.02(1.00-1.03)	0.04			0.99(0.98-1.01)	0.34

^*all patients in the hypomutation group lived no more than 5-years